All News

Officials with the FDA have approved Amgen’s infliximab-axxq (Avsola), a new biosimiliar to infliximab (Remicade).

Studying individuals’ genomes can help influence how different medications work for a patient, avoid harmful adverse drug reactions, and allow scientists to develop personalized medicines for patients with a wide range of diseases and disorders.

Top articles of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Fingolimod treats relapsing forms of multiple sclerosis in adult patients.

As more vaping cases are reported, patients may desire answers from their trusted providers.

A new method of targeted radiation therapy sends alpha-emitting particles directly to stroma cells in pancreatic cancer tissue.

The OTC Guide survey will be open for pharmacists to participate from Nov. 15, 2019, to March 1, 2020.

Top news of the day from across the health care landscape.

Men with breast cancer had higher mortality than women regardless of cancer type, treatment, and access to care.

Louisiana, Nevada, Texas rank highest in flu activity for the month of November.

Amneal has begun commercialization activities for the generic versions of sildenafil for oral suspension 10 mg/ml and aminocaproic acid tablets USP, 500 mg.

The approval for the first generic sucralfate oral suspension is 1 of the 15 complex products the manufacturer expects to launch over an 18- to 24-month period.

Understanding adherence patterns is the first step to combat the HIV epidemic in this population.

Top news of the day from across the health care landscape.

Psychological factors such as anxiety and depression can directly influence a patient’s experience with cancer-related pain.

Approval was based on results from the phase 3 Impower130 study, which showed atezolizumab in combination with chemotherapy increased overall survival in participants compared with chemotherapy alone.

Emmes, a scientific research company, will support the development of a universal influenza vaccine that could provide longer-lasting protection than the current vaccines available.

Top news of the day from across the health care landscape.

Social interactions between hypothetical health care providers and patients have the power to influence a patient’s perception on the efficacy of a treatment.